A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.
Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers.
Patient Declaration covers commitments in five key areas
With ViaOpta Nav, visually impaired people can now use Apple watches and Android Wear devices to navigate to and from places with greater ease.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.